WEED Stock Price Quote | Morningstar
Skip to Content

Canopy Growth Corp WEED

Morningstar Rating
CAD 11.86 −0.41 (3.34%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

First Pillar of Germany's Cannabis Legalization Begins April 1; Legal Sales to Come Later

The Bundestag, the lower house of Germany’s legislature, passed a cannabis bill last month that would allow possession of up to 25 grams and home-growing of up to three plants. The law will become effective April 1 as planned after the Bundesrat, the upper house, voted not to send it to mediation committee on March 22. The law expands on July 1 to allow nonprofit cannabis grow clubs of up to 500 members and 50 grams per member.

Price vs Fair Value

WEED is trading at a 19% premium.
Price
CAD 10.79
Fair Value
CAD 4.70
Uncertainty
Extreme
1-Star Price
CAD 84.90
5-Star Price
CAD 7.73
Economic Moat
Fpslz
Capital Allocation
Qlctf

Bulls Say, Bears Say

Bulls

Canopy Growth’s plans to create Canopy USA to strengthen its competitive position before U.S. federal legalization.

Bears

While Canopy waits for U.S. federal legalization to enter the THC market there, U.S. multistate operators continue to grow bigger and become more competitive.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if WEED is a good fit for your portfolio.

News

Trading Information

Previous Close Price
CAD 12.27
Day Range
CAD 11.8512.46
52-Week Range
CAD 3.7426.00
Bid/Ask
CAD 11.85 / CAD 11.87
Market Cap
CAD 1.08 Bil
Volume/Avg
2.1 Mil / 3.2 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.68
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
1,621
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRLkgnhwbjXchff$70.9 Bil
ZTS
Zoetis Inc Class ALrxnkpbhWwgl$68.9 Bil
HLN
Haleon PLC ADRDttmnjpLmpz$37.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRJwcbscywHcbbr$14.7 Bil
VTRS
Viatris IncFbrbskqsgPtp$13.7 Bil
RDY
Dr Reddy's Laboratories Ltd ADRWglcxskzMhwx$11.9 Bil
CTLT
Catalent IncHvfbcsbfChfgjz$10.1 Bil
PRGO
Perrigo Co PLCHwjrxsnmsSlc$4.1 Bil
CURLF
Curaleaf Holdings IncYgbmmzwfBczp$3.6 Bil
PBH
Prestige Consumer Healthcare IncYmycgcfwjJjbbrv$3.5 Bil

Sponsor Center